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Background: Chalcone Panduratin A (PA) has been known for its antioxidant property, but its merits against
oxidative damage in liver cells has yet to be investigated. Hence, the paper aimed at accomplishing this task with
normal embryonic cell line WRL-68.
Methods: PA was isolated from Boesenbergia rotunda rhizomes and its 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging
and ferric reducing power (FRAP) activities were measured in comparison with that of the standard reference drug
Silymarin (SI). Oxidative damage was induced by treating the cells with 0.04 g/ml of toxic thioacetamide for 60 minutes
followed by treatment with 1, 10 and 100 μg/ml concentrations of either PA or SI. The severities of oxidative stress in
the control and experimental groups of cells were measured by Malondialdehyde (MDA) levels, superoxide dismutase
(SOD), catalase (CAT) and glutathione peroxidase (GPx) activities.
Results: PA exhibited an acceptable DPPH scavenging and FRAP activities close to that of Silymarin. Treating the injured
cells with PA significantly reduced the MDA level and increased the cell viability, comparable to SI. The activities of SOD,
CAT and GPx were significantly elevated in the PA-treated cells in a dose dependent manner and again similar to SI.
Conclusion: Collectively, data suggested that PA has capacity to protect normal liver cells from oxidative damage,
most likely via its antioxidant scavenging ability.
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Oxidative stressBackground
Boesenbergia rotunda (BR) is a perennial herb belonging
to family Zingberaceae and traditionally used as folk
medicine for treating diseases such as stomach discom-
fort, dysentery and leucorrhea in Southeast Asia. Past
research have revealed that BR extract has an anti-
cancer, antibacterial and neuroprotective properties
[1-4]. In our previous in vivo experimental study, we
have demonstrated that BR extract is hepatoprotective in
liver cirrhosis [2]. Treatment of thioacetamide-induced
hepatotoxicity with the extract was shown to maintain* Correspondence: mehmet.bilgen@yahoo.com
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reproduction in any medium, provided the ornormal hepatic architecture and liver function by slo-
wing down the progressive liver damage. Panduratin A
(PA) is one of the chalcones present in the BR extract
[5] and exhibits anti-inflammatory [5], anti-oxidant [3],
antibacterial [6], anti-dengue [7], anti-mutagenic [8] acti-
vities. Cheah et al. 2011 reported that 30 μM (12.1 μg/mL)
dose of PA is cytostatic but not cytotoxic to normal
embryonic cell line WRL-68 [9]. Based on these multi-
functions of PA, it is plausible that our previous findings
on the hepatoprotectivity of the BR extract against liver
cirrhosis may in part be due to the presence of this
compound in the extract. Therefore, this study was initi-
ated to investigate the hepatoprotective activity of PA
when administered alone, specifically in thioacetamide-
induced cytotoxicity, with in vitro experiments usingLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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perimental procedures, present results and discuss our
findings in the context of this objective.
Methods
Isolation of the compound Panduratin A from
Boesenbergia rotunda extract
Ethanol based extract was obtained from Boesenbergia
rotunda rhizomes (BR) by following the procedures
described in our previous paper [2]. Briefly, fresh BR
rhizomes were purchased from a company (Ethno
Resources Sdn Bhd, Selangor, Malaysia) and identified
by comparing against the specimen deposited at the
Harbarium of Rimba Ilmu (Voucher number KU0098,
Institute of Science Biology, University of Malaya, Kuala
Lumpur). After washing the rhizomes with tap water
first and then rinsing with distilled water, they were
sliced and dried for 10 days. The dry samples were finely
grounded, and 100 g of the resulting powder was mixed
in 1000 mL solution of 95% ethanol for 7 days at room
temperature. The mixture was distilled, and dried at
40°C in an incubator for 3 days giving a gummy yield of
BR extract at 9.49% (w/w). Next, PA was isolated from
this product. Specifically, 2.67 g of the extract sample
was dissolved in acetone (Merck AR Grade, Malaysia)
and further mixed with 5 g of silica gel (Silicycle, Ultra-
pure Silica Gel, Canada). The final mixture was dried
using a rotary evaporator. The resulting powder was
subjected to column chromatography (CC) containing
47 g of silica gel. The fractionation/isolation step was
based on gradient elution method [10] with the Hexane-
Ethyl acetate (Fisher Scientific AR Grade, UK) solvent
system. A total of 11 fractions afforded. A Thin Layer
Chromatography (Merck, Silica gel 60 F254, Japan) of
the 11 fractions versus PA standard (98% purity) was
carried out at the ratio of 95:5. Fraction BR-3 containing
PA (Rf 0.29) was dried using a rotary evaporator and
weighed using analytical balance to obtain 0.767 g pure
crystals of PA (96.6%) as confirmed by High Perform-
ance Liquid Chromatography (HPLC) and calculated by
the following formula:
% Purity ¼ Peak Area of Panduratin A=
Total Peak Area−Peak Area of Solventð Þ:
The mass of the isolated PA was determined by LCMS
using METLIN DATABASE.
DPPH scavenging activity of Panduratin A
The antioxidant power of the isolated compound PA
was examined first by using 2,2-Diphenyl-1-picrylhydra-
zyl (DPPH) stable free radical scavenging assay as
described by Brand et al. [11], but with a minor modifica-
tion. The test involved dissolving 1 mg of the compoundin 1 ml dimethyl sulfoxide (DMSO) (Fisher Medical, UK)
and then further diluting into three different concentra-
tions 1, 10 and 100 μg/mL. In addition, ascorbic acid and
Quercetin were utilized as antioxidant standards and
Silymarin was used as an antioxidant reference drug [12].
Amount (5 μL) of the compound and the standard were
mixed with 195 μL of DPPH in triplicate using DMSO as
blank. The decrease in absorbance value was assessed at
515 nm for 2 hr with 20 min gaps. Any antioxidant do-
nates an electron to DPPH and the usual purple hue seen
for free DPPH radical decays to yield a change in absorb-
ency. The radical scavenging activity was quantified using
the equation:
% of fundamental scavenging activity
¼ Abs blank − Abs sampleð Þ  100=Abs blank:
Ferric reducing power (FRAP) of Panduratin A
The anti-oxidant power of PA was also determined using a
test sensitive to its scavenging ability towards reactive oxy-
gen species or reagents containing iron. In this regard, the
ferric reducing anti-oxidant power (FRAP) of the isolated
compound was determined using an assay by following the
method described in [13], with a slight modification. The
FRAP reagent was prepared by mixing 300 mM acetate
buffer (3.1 mg sodium acetate/ml, pH 3.6), 10 mM 2,4,6-
tripyridyl-S-triazine (TPTZ) (Merck, Darmstadt-Germany)
solution [14] and 20 mM FeCl3.H2O (5.4 mg/mL). Pandur-
atin A compound, and the standards; Ascorbic acid and
Quercetin were dissolved in DMSO and sampled in
amounts of 10 μL of 1 μg/mL along with 10 μL of 1 μg/mL
silymarin and added into 300 μL of the reagent TPTZ sep-
arately in triplicate using DMSO as blank. The absorbencies
of the resulting mixtures were read using ELISA reader
(UV 1601 spectrophotometer, Shimadzu, Kyoto, Japan) at
593 nm wavelength at 0 minute and after 4 minutes. The
readings from the compound and silymarin were compared
against the standards; Ascorbic acid and Quercetin [15].
In vitro experiments
In vitro experiments involved acquiring a hepatic cell line,
exposing cells to different concentrations of PA to show that
PA is nontoxic, then subjecting the cells to toxicity through
thioacetamide (TAA) and finally demonstrating that PA is
effective in preventing the death of cells from TAA toxicity.
Cell culture
Human embryonic normal liver cell line (WRL-68) was
originally acquired from American Type Culture
Collection ATCC and cultured in our institute. The cells
were grown and maintained at 37°C by a 5% CO2 incu-
bator (NuAire Inc., Plymouth, USA). When needed for
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with density 3000 cells/well in 200 μL of RPMI-1640
containing 10% FBS and 1% (v/v) penicillin-streptomycin
remedy, and incubated at 37°C and 5% CO2 for 24 hours
before starting the experimentation [16].Determination of the IC50 dose of thioacetamide
To induce oxidative damage, WRL-68 cells were sub-
jected to a toxic insult by TAA exposure. TAA has a
short half-life and is metabolized in the microsomes of
hepatocytes [17], but induces cytotoxicity in normal cells
[6,7]. IC50 denotes inhibition concentration, i.e., concen-
tration of TAA that causes the death of 50 % of the cells.
Three different concentrations 0.03, 0.04, 0.05 g/ml of
TAA were prepared by dissolving its crystals in sterile
distilled water. These three concentrations were selected
based on the previous publication, but stated as g/mL,
and indicate amounts which cause oxidative damage to
the cells [18]. The cells in three of the four wells were
exposed to these concentration amounts by delivery in
10 μl, as one concentration per well, separately. The un-
exposed cells in the fourth well again served as control.
As shown in results section, 0.04 g/ml was determined
as the optimum IC50 dose. The percentage of cell viabil-
ity was calculated by the formula:
% Cell Viability ¼ ðAbsorbance of the TAA−treated cells=
Absorbance of sterile distilled water
−treated cellsÞ  100:
Effects of Panduratin A in TAA-cytotoxicity
The WRL-68 cells in three of the four wells were treated
with 10 μL of the optimum IC50 dose 0.04 g/mL of
TAA. The cells in the fourth well served as normal con-
trol group. The cells in all four wells were incubated for
one hour and then PA was added in concentrations of 1,
10 and 100 μg/mL, as in the experimentation aimed at
determining the cytotoxicity of isolated PA above. The
cells were incubated for 24, 48 or 72 hours and their via-
bilities were determined similarly.
Silymarin (SI) is a purified extract and used widely as a
supportive therapy for liver disorders such as cirrhosis,
hepatitis and fatty acid infiltration due to alcohol or
toxic chemicals [14]. We also compared the effects
achieved with PA on the TAA-cytotoxicity against the
benchmark protection provided by SI [14,19]. The con-
centrations of SI were kept the same as those of PA.
Concentrations of 1, 10 and 100 μg/mL of SI were re-
spectively delivered to the cells in three separate wells,
each in triplicate and their viabilities were evaluated at
either 24, 48 or 72 hours [20].Assessment of MDA Level, CAT, SOD and GPx Activities
The following experiments were conducted to demon-
strate the oxidative damage in the cells treated with the
PA +TAA or SI + TAA compared to those treated with
TAA only through the measurements in the levels of
MDA and antioxidant enzymes (CAT, SOD and GPx)
[14,19]. The cells were seeded and incubated first for one
hour with 0.04 g/mL TAA and then treated with com-
pounds PA or SI (1, 10, 100 μg/mL) as mentioned previ-
ously. After 72 hours of incubation at 37°C and 5% CO2,
all cells were washed twice with 300 μl Phosphate Buffered
Saline (PBS), pH 7.4. The cells were detached using a ster-
ilized scrapper and lysed in 25 mmol/LTris–HCl lysis buf-
fer with no protease or phosphatase inhibitors used. The
homogenate was thensonicated on ice (10 s pulse) and
finally centrifuged at 13000 xg for 15 minutes. The result-
ing cell lysate was collected and kept at −20°C for assaying
CAT, SOD, GPx and MDA following the instructions in
the kit manuals of Cayman kits, USA (Cat. # 707002 for
CAT, # 706002 for SOD, # 703102 for GPx and #
10009055 for MDA). Protein concentration in the cell lys-
ate was evaluated using a standard method [21].
Statistical analysis
All outcomes including the measured concentrations of the
proteins CAT, SOD, GPx and MDA were evaluated statisti-
cally and the final results were expressed as Mean ± SEM
(standard error in the mean) while n = 3. The data were an-
alyzed by one-way analysis (ANOVA) followed by Tukey
Post-Hoc test using SPSS (Version 18, SPSS Inc., Chi town,
IL, USA). The level of significance was set at p < 0.05.
Results
HPLC and LCMS of PA
Dry pack column chromatography of B. rotunda crude
extract resulted in 11 fractions. The results of TLC of all
fractions versus PA compound showed that fraction
BR-3 contained panduratin A recording retardation fac-
tor similar to that of PA standard (Rf = 0.29). These re-
sults were also confirmed by High performance liquid
chromatography (Figure 1a and b). LCMS chromato-
gram of the isolated PA is illustrated in Figure 1c show-
ing that the compound was detected at m/z 407.2211.
DPPH scavenging activity
Panduratin A compound exhibited comparable free rad-
ical scavenging activity for DPPH compared to that of
Quercetin (QU) and Ascorbic acid (AC) as shown in
(Figure 2) (standard curve equation: y = 1.02333× –
0.1305, R2 = 0.9925). At the highest tested concentra-
tions 100 μg/mL, the DPPH inhibition % of PA was sig-
nificantly (P < 0.001) lower than that of the standards
AC and QU and the reference drug Silymarin. On the
other hand, at the lowest tested concentration 1 μg/mL,
Figure 1 Isolation of Panduratin A compound from the ethanol extract of Boesenbergia rotunda rhizomes. (a) HPLC profile of BR-3
showing Panduratin A compound. (b) HPLC profile of Panduratin A standard. (c) Mass spectrum of Panduratin A. (d) Panduratin A (C26H30O4)
structure. (e) Pale yellow crystals of isolated Panduratin A.































DPPH free radical scavenging activity
#
Figure 2 Percentage inhibition of DPPH scavenging activity of Panduratin A compound (PA) compared with the standards Ascorbic
acid (AC) and Quercetin (QU) and the reference drug Silymarin (SI). Values are expressed as Mean ± SEM, while n = 3 *P<0.001 compared to
AC100 and QU100. #P<0.01 compared to SI100.
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AC and QU or between PA and the standard drug SI.
The medium concentration 10 μg/mL revealed low sig-
nificance (P < 0.001) between PA and the standards AC
and QU, while the significance detected between PA and
SI was P = 0.52. These results indicated that PA had less
potent radical scavenging effect and antioxidant activity
than AC and QU, but similar to that of the reference
drug SI at the low and medium concentrations 1 and
10 μg/mL, but not at the high concentration 100 μg/mL.
FRAP value of PA
As illustrated in Figure 3, the ferric reducing antioxidant
power (FRAP) of Panduratin A was significantly lower
(P < 0.01) (1.11 ± 0.13 mmol FeII/μg) than that of























Figure 3 Ferric reducing power (FRAP) of The isolated Panduratin A c
as well as the standard drug Silymarin. Values are expressed as Mean ±
to Ascorbic acid and Quercetin. #P<0.05 compared to Ascorbic acid. No sig0.74 mmol FeII/μg respectively), while the standard
curve equation recorded y = 0.0006× + 0.624 and R2 =
0.9875. On the other hand, there was no significant dif-
ference between the measured FRAP value of Pandura-
tin A and the standard drug Silymarin (1.72 ± 0.24 mmol
FeII/μg). Further, the results revealed significant de-
crease in the FRAP value of Silymarin compared to
Ascorbic acid (P < 0.01) and Quercetin (P < 0.05). Based
on these readings, it is reasonable to extrapolate that
Panduratin A exhibits an acceptable antioxidant activity
similar to that of the standard drug Silymarin.
In vitro protective activity of PA against TAA cytotoxicity
IC50 of TAA
The percentage viability of WRL-68 cells after being in-




ompound compared with the standards; Ascorbic acid, Quercetin
SEM, While n = 3 *P<0.01 compared to Quercetin. **P<0.01 compared
nificance difference between Panduratin A and Silymarin.
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trated in Figure 4. Results showed that the IC50 dose of
TAA is 0.04 g/mL at 60 min of incubation.
Protective effect of PA compound against TAA-toxicity
The results of treating WRL-68 cells after being incu-
bated for 60 minutes with TAA with three different con-
centrations of PA and SI compounds are shown in
Figure 5. The data showed that, only about 35 % of the
untreated cells remained alive at 24, 48 or 72 hours after
being exposed to TAA. But, treatment of the cells with
either PA or SI increased the cell survival significantly to
about 90 % irrespective of the dose amount and the
measurement time. No significant differences in the per-
centages of cell viabilities were recorded between the PA
or SI treated cells indicating that PA had nearly the same
protective effect as SI against TAA-cytotoxicity.
MDA and the antioxidant enzyme CAT, SOD and GPx
assays
As shown in Figure 6, treating WRL-68 cells with
0.04 g/mL TAA for 60 minutes markedly elevated the
MDA protein level to 14.33 ± 0.88 nmoL/mg protein and
reduced the antioxidant enzymes CAT, SOD and GP×
activities to 4.97 ± 0.55 nmoL/min/mL, 5.00 ± 0.58 U/mL
and 7.00 ± 1.15 nmol/min/mL, respectively compared to
normal control cells (MDA: 6.50 ± 1.44 nmoL/mg pro-
tein, CAT: 12.67 ± 0.88 nmoL/min/mL, SOD: 12.83 ±
1.48 U/mL and GPx: 21.97 ± 1.18 nmoL/min/mL). PA
treatment was effective towards the restoration of these
biomarkers to their normal levels, as the dose increased.
The highest dose 100 μg/mL of PA attenuated the pro-
tein MDA level back to 7.00 ± 1.15 nmoL/mg protein
and increased the activities of antioxidant enzymes CAT,


















Figure 4 IC50 of TAA. Data were expressed as Mean ± SEM, while n =
compared with TAA-treated cell (0.04 g/ml). D.W: distilled water; TAA: thioa1.51 U/mL and 20.40 ± nmol/min/ml, respectively. There
was no significant difference between the results ob-
tained from treating the cells with either PA or SI at
identical doses, indicating that PA was as effective as SI
in protecting the cells against oxidative stress.
Discussion
Liver cirrhosis is becoming more prevalent in today’s
modern life as the health medications with side effects
are increasingly being used. Consequently, current re-
search targets new counteractive pharmaceutical solu-
tions to tackle with this serious clinical problem [22].
Natural compounds or products extracted from folk me-
dicinal plants are specifically investigated as potential
therapeutic sources [23]. Efforts have been focused on
evaluating their protective functions, especially with an-
tioxidative impact, and also mechanisms of action in liv-
ing model systems.
Phenolic substances present in the vegetation are
regarded as nutritional antioxidants [24]. Chalcones are
groups of phenolic compounds from the flavonoid family
and exhibit a range of bioactivities, including anticancer
[25] and antioxidative [24]. The anti-oxidant action of
chalcones is relevant to various mechanisms such as
quenching singlet oxygen, hydrogen atom or electron
transfer and act as substrate for superoxide and hydrox-
ide radicals. Anto et al. [26] tested 33 chalcones and
chalcone related compounds and reported that most
chalcones have high superoxide radical scavenging activ-
ity and Yayli et al. [27] confirmed these results. In the
present study, the procedure of isolating PA from the
ethanolic extract of B. rotunda rhizomes could isolate
highly purified crystals of the compound and the quan-
tity produced indicates that PA constitutes about 29%





























Figure 5 The protective effect of Panduratin A (PA) against TAA toxicity in the WRL-68 cells. Data were expressed as Mean ± SEM, while
n = 3. Note that the data indicates % Cell variability exceeding 100 %, which means that PA not only protects the cells from the toxic effect of
TAA, but also increases the cell proliferation to exceed the number of cells in the normal control.
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an odd electron, is commonly used in chemical analysis
procedures to measure free radical scavenging activity
of compounds [28]. Panduratin A is one of the natural














































Figure 6 The effect of Panduratin A (PA) treatment on oxidative stres
activity (b) SOD, (c) CAT and (d) GPx of TAA-induced oxidative damage in
60 minutes followed by the addition of 1, 10 and 100 μg/mL of the mentio
± SEM, while n = 3. *P< 0.01 compared to normal control and **P<0.05 coextract and it’s previously demonstrated favorable bio-
logical activities made it attractive for investigating its
merits as a potential therapy for the treatment liver
cirrhosis in this research. Our results revealed that















































s and cellular antioxidant enzymes. (a) MDA and the antioxidant
WRL-68 cell line. WRL-68 cells were treated with TAA (0.04 g/mL) for
ned PA extract and the SI compound. Data were expressed as Mean
mpared to toxin control.
Salama et al. BMC Complementary and Alternative Medicine 2013, 13:279 Page 8 of 9
http://www.biomedcentral.com/1472-6882/13/279(Figure 2) and ferric reducing power (Figure 3) when
compared to the standard reference drugs. This was in
line with the known property, i.e. high free radical scav-
enging activity, of chalcones [29].
Examining the cytotoxicity of Panduratin A on WRL-
68 cell line revealed that PA was not cytotoxic even at the
highest concentration of 100 μg/mL. This was in agree-
ment with the findings from PA tests on different cell lines
[3] where it was shown that 50 μM (20.3 μg/mL) of
PA was not toxic.
TAA induces the production of reactive oxygen species
(ROS) through its hydrolysis producing H2S as one of
the reaction products [30]. Additionally, inside liver
cells, H2S cytotoxicity elevates the level of ROS which
are normally produced during cellular respiration deplet-
ing the level of antioxidant enzymes [31]. but, isolated
compounds from plant extracts can effectively protect
the hepatocytes from TAA-cytotoxicity [2,18]. Studies
with cultured cells have proven the participation of oxi-
dative stress in the etiology of TAA-induced oxidative
damage [14,19]. TAA triggers fat peroxidation [32]; in-
creases the vulnerability of hepatocytes to fat peroxidation
[33]; and decreases the amount of endogenous anti-
oxidant enzymes [34]. We determined that IC50 dose of
TAA was 0.04 g/mL at 60 min of incubation with normal
hepatocytes (Figure 4). PA treatment increased the viabil-
ity of the TAA-exposed cells, implicating the protective ac-
tivity of PA against TAA-cytotoxicity (Figure 5) which can
be attributed to PA scavenging activity to ROS.
The hepatoprotective action was also confirmed by the
levels of MDA and antioxidant enzymes (CAT, SOD and
GPx) (Figure 6). As shown in Figure 6A, the high level
of MDA in the cell lysate collected from the toxin con-
trol indicated that TAA triggered oxidative damage to
cell membranes of liver cells. Fat peroxidation was
started by reactive oxygen species (ROS) damaging the
unsaturated fatty acids and spread by a chain reaction
cycle including fats, lipid hydroperoxides and peroxy
radicals [32] altering the cell membrane permeability
and resulting in interruption in the structure and func-
tion of the membrane. The results of the present study
suggest that panduratin A is able to reverse the hepato-
cyte lipid peroxidation brought on by TAA.
It is well recognized that cellular antioxdant enzymes,
the most essential biomolecules defending against oxida-
tive stress [35], can get involved in the decrease of sensi-
tive intermediates. Anti-oxidants which can restrict the
production of free radicals are essential with regards to
defending the liver cells from toxin-induced damage
by counterbalancing the cellular anti-oxidant systems.
Whereas, some chalcones were found to inhibit glutathi-
one and glutathione peroxidase (GPx) in hydrogen
peroxide (H2O2) induced toxicity in liver cancer cells
HepG2 [36], but other chalcones were proved to increasethe endogenous cellular enzymes SOD, CAT and GPx in
Hydrogen peroxide-oxidative stress in neuroblastoma
cells [37]. On the other hand, studies showed that chal-
cones have efficacy in inhibiting lipid peroxidation [30].
Our research revealed that TAA triggered ROS overpro-
duction and decreased the cellular anti-oxidant enzymes
SOD, CAT and GPx in the WRL-68 cells. The data
further showed that SOD, CAT and GPx depletion due
to TAA was recovered when the damaged cells were
treated with panduratin A and the recovery was dose-
dependent (Figure 6B, C and D). These positive results
may be due to free-radical scavenging power of the chal-
cone PA as assisted by the percentage inhibition of
DPPH scavenging activity of PA similarly to the refer-
ence drug Silymarin (Figure 2).
Conclusion
Protecting hepatocytes in vitro from TAA-induced dam-
age seems to be feasible when treated with Panduratin
A. But, if the same would hold under in vivo conditions,
i.e. if the liver’s structure and functions against toxins
can be protected with PA, and if PA would play pharma-
cologic role in liver cirrhosis need further explorations.
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